These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26948084)

  • 1. Assessment of Drug-Drug Interaction between Warfarin and Aprepitant and Its Effects on PT-INR of Patients Receiving Anticancer Chemotherapy.
    Takaki J; Ohno Y; Yamada M; Yamaguchi R; Hisaka A; Suzuki H
    Biol Pharm Bull; 2016 May; 39(5):863-8. PubMed ID: 26948084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin.
    Depré M; Van Hecken A; Oeyen M; De Lepeleire I; Laethem T; Rothenberg P; Petty KJ; Majumdar A; Crumley T; Panebianco D; Bergman A; de Hoon JN
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):341-6. PubMed ID: 15983826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy.
    Ohno Y; Yamada M; Yamaguchi R; Hisaka A; Suzuki H
    Int J Clin Pharm; 2014 Dec; 36(6):1134-7. PubMed ID: 25288146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient elevation of international normalized ratio during cisplatin-based chemotherapy in patients who are taking warfarin.
    Yano R; Kurokawa T; Tsuyoshi H; Shinagawa A; Sawamura Y; Matsunaga A; Nakamura T; Yoshida Y; Yoneda M; Kotsuji F; Masada M
    Ann Pharmacother; 2011 Oct; 45(10):e55. PubMed ID: 21881031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of an Increase in Prothrombin Time-International Normalized Ratio by Interaction Between Warfarin and Baloxavir Marboxil in a Patient on Implantable Ventricular Assist Device.
    Kurosawa K; Takasaki S; Suzuki H; Sato Y; Akiyama M; Akiba M; Saiki Y; Mano N
    J Pharm Pharm Sci; 2021; 24():37-40. PubMed ID: 33460556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions with aprepitant or fosaprepitant: Review of literature and implications for clinical practice.
    Dushenkov A; Kalabalik J; Carbone A; Jungsuwadee P
    J Oncol Pharm Pract; 2017 Jun; 23(4):296-308. PubMed ID: 26921085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects.
    Moore KT; Byra W; Vaidyanathan S; Natarajan J; Ariyawansa J; Salih H; Turner KC
    Br J Clin Pharmacol; 2015 Jun; 79(6):907-17. PubMed ID: 25475601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery.
    Katada Y; Nakagawa S; Nishimura A; Sato YK; Taue H; Matsumura K; Yamazaki K; Minakata K; Yano I; Omura T; Imai S; Yonezawa A; Sato Y; Nakagawa T; Minatoya K; Matsubara K
    Eur J Clin Pharmacol; 2019 Apr; 75(4):561-568. PubMed ID: 30460405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Study on Drug Interaction between Warfarin and Capecitabine with Special Reference to the Co-Administered Term or the Discontinuation Term of Capecitabine.
    Ikenishi M; Ueda M; Kuroda A; Tsukazaki H; Nakao M; Takeuchi M; Konishi Y; Matsuda T; Figoni W; Ohtori T; Matsuyama K; Satoh H; Sawada Y; Nakatsuka E
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):833-9. PubMed ID: 26197745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin.
    Suzuki S; Ikegawa K; Yamamoto K; Saito S
    J Int Med Res; 2016 Oct; 44(5):1123-1130. PubMed ID: 27553806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Tramadol Coadministration on Prothrombin Time-International Normalized Ratio in Patients Receiving Warfarin].
    Hosono T; Kondo A; Kambayashi Y; Homma M
    Yakugaku Zasshi; 2017; 137(8):999-1003. PubMed ID: 28768953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide and etoposide chemotherapy may interact with warfarin, enhancing the warfarin induced anticoagulant response.
    Okada N; Watanabe H; Kagami S; Ishizawa K
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):58-61. PubMed ID: 26587904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin.
    Turrentine MA
    Obstet Gynecol; 2006 Feb; 107(2 Pt 1):310-3. PubMed ID: 16449117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Seven Tyrosine Kinase Inhibitors on the Anticoagulation Activity of Warfarin].
    Hiraide M; Minowa Y; Nakano Y; Suzuki K; Shiga T; Miyoshi J; Takahashi H; Hama T
    Gan To Kagaku Ryoho; 2019 Nov; 46(11):1733-1739. PubMed ID: 31748483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between Warfarin and Linezolid in Patients with Left Ventricular Assist System in Japan.
    Kinoshita S; Wada K; Matsuda S; Kuwahara T; Sunami H; Sato T; Seguchi O; Yanase M; Nakatani T; Takada M
    Intern Med; 2016; 55(7):719-24. PubMed ID: 27041154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of Drug Interaction between S-1 and Warfarin].
    Yamamoto K; Suzuki S; Ikegawa K; Nomura H; Fuse N; Saito S
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):65-8. PubMed ID: 26809527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.